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Insertion-deletion polymorphism (InDeL) is the second most frequent type of genetic variation in the human genome. For
the detection of large InDeLs, researchers usually resort to either PCR gel analysis or RFLP, but these are time consuming
and dependent on human interpretation. Therefore, a more eﬃcient method for genotyping this kind of genetic variation is
needed. In this report, we describe a method that can detect large InDeLs by DHPLC (denaturating high-performance liquid
chromatography) using the angiotensin-converting enzyme (ACE) gene I/D polymorphism as a model. The InDeL targeted in this
study is characterized by a 288bp Alu element insertion (I). We used DHPLC at nondenaturating conditions to analyze the PCR
product with a ﬂow through the chromatographic column under two diﬀerent gradients based on the diﬀerences between D and
I sequences. The analysis described is quick and easy, making this technique a suitable and eﬃcient means for DHPLC users to
screen InDeLs in genetic epidemiological studies.
Copyright © 2008 Renata Guedes Koyama et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Insertion-deletion (InDel) polymorphisms are an important
and abundant form of human genome variation; they are
the second most frequent type of polymorphisms in the
human genome and may be observed at the level of single-
basepairs,multibasepairexpansionsofrepeatunits,random
DNA sequence insertions and deletions, and as transposon
insertions. This kind of DNA polymorphism can be used for
the purpose of genetic mapping and diagnostics [1].
It is well known that translocation insertions and gross
deletions (>100pb) are important causes of both cancer
and inherited diseases. Microdeletions and microinsertions
(≤20bp) account for 17% of all inherited diseases, as
reported in the May 2007 release of the human gene
mutation database (www.hgmd.org/).
An example of such polymorphism is the inser-
tion/deletion (I/D) in the angiotensin-converting enzyme
(ACE) gene that has been associated with many diseases,
particularly of the cardiovascular system. Reports of such
associations include risk of myocardial infarction and car-
diovascular disease, ischemic stroke, eﬀects on response of
human muscle to strength training [2–6], and hypertension
insubjectswithmildtomoderatedegreesofsleepapnea(5 ≤
apnea-hypopnea index ≤ 30) [7].
In the renin-angiotensin system, ACE is a well-known
zinc metallopeptidase that is widely distributed on the
surface of endothelial and epithelial cells. ACE plays a role
in the conversion of the inactive decapeptide, angiotensin I
(Ang I or Ang 1–10), into the active octapepptide and potent
vasoconstrictor angiotensin II (Ang II or Ang 1–8) as well as
in the inactivation of the vasodilator bradykinin [8, 9].
The ACE InDel polymorphism is characterized by the
presence (insertion, I) or absence (deletion, D) of a 288bp
DNA sequence in intron 16 of the gene. This insertion
sequence is an Alu element (three Alu-repeat).
Although several genetic studies of the ACE D allele have
associated polymorphism with cardiovascular disease, these
data are questionable due to probable mistyping of the ACE I
allele [10]. This problem occurs because of the diﬀerent sizes2 Journal of Biomedicine and Biotechnology
of I and D allele PCR products, which are 490bp and 190bp,
respectively. But it happens that the D (shorter) allele possess
the property of being preferentially ampliﬁed compared to
the I allele, and this diﬀerential response to ampliﬁcation
may lead to mistyping of the ID sample.
Conﬂicting reports of ACE I/D frequencies have also
been described, given the diﬃcult nature of this geno-
typing. The diversity of ﬁndings has been attributed to
methodological and technical variations in detection of the
polymorphisms [11].
TheﬁrstdescriptionofACEI/Dpolymorphismgenotyp-
ing proposed by Rigat et al. [12] was a PCR method using a
set of primers ﬂanking the insertion. However, as mentioned
earlier, the D allele is preferentially ampliﬁed, so the ID
heterozygote can be mistyped as DD, thus causing a higher
frequency for this genotype. The probability of this mistyp-
ing has been estimated to be 5–10% [13, 14]. Therefore,
careful control is required and repeated testing is also often
necessary, especially when verifying the ID heterozygote.
This method has been modiﬁed several times, and a
conﬁrmatory PCR has been proposed by Shanmugan et al.
[15] to minimize mistyping of the I allele as a D allele. In this
method, a new sense primer is used inside the Alu sequence,
resultinginampliﬁcationofa408bpfragmentofalleleI.The
D allele shows no ampliﬁcation under this condition due to
lack of an annealing site for the new sense primer, so it works
asanadditionalampliﬁcationaftertheconventionalmethod.
The authors reported 100% accuracy with this methodology.
However, use of a primer annealing inside an Alu sequence
maycausenonspeciﬁcannealingduetostructuraldiﬀerences
in the I and D allele in which there are three Alu sequences.
Therefore, problems with preferential ampliﬁcation by PCR
arenotentirelyexcludedwiththismethod[16].Eighthuman
genes speciﬁc to Alu insertion polymorphisms have been
described (ACE, TPA25, PV92, APO, FXIIIB, D1, A25,a n d
B65)[ 17], and theoretically, any of them can be ampliﬁed
by PCR using a primer that anneals in the Alu sequence.
Moreover, this methodology generally involves various steps
and is time consuming.
Other modiﬁcations have included a step-down PCR,
as described by Chiang et al. [16], which aims to increase
the product and the detection rate of the I allele. This
method involves initial PCR annealing temperatures higher
than the melting point of the primers, followed by annealing
temperatures reduced stepwise to the melting point. In this
technique with high ampliﬁcation failure, the results should
be interpreted by two diﬀerent observers, and consensus
opinions have to be obtained from a third observer blinded
to the results from the other two.
The low resolution of these methods can lead to dif-
ﬁculties in data interpretation, and also requires various
time-consuming steps. Therefore, a more eﬃcient means
of ACE genotyping is particularly desirable for clinical and
epidemiologic investigations. Other techniques have been
purposed, such as real-time PCR [18], to detect ACE ID
polymorphism, but this has not been used in genetic associ-
ation studies, likely because of the need for speciﬁc and more
expensive reagents. The multiplex approach, proposed by
Evans et al. [19], improves the accuracy of ACE genotyping,
but presents diﬃculties in the post-PCR handling, such
as agarose diagonal gel electrophoresis. Moreover, to our
knowledge, the multiplex approach is speciﬁc to ACE InDel
genotyping and cannot be extended to other systems.
Here, we report a protocol using DHPLC (denaturating
high-performance liquid chromatography)to genotype large
InDels employing the ACE gene I/D polymorphism as a
model. The major advantage of this method is the ease
it provides in screening a large number of samples while
avoiding electrophoresis and gel analysis.
The technique is based on automated detection of DNA
segments by ion-pair reverse-phase high performance liquid
chromatography [20]. This approach normally compares
two alleles after denaturing and reannealing PCR amplicons.
In this methodology, a preliminary quality analysis of the
amplicon is always done in nondenaturing conditions at
50◦C in order to quantify and verify the quality of the PCR
product.Undersuchnondenaturingconditions,thepresence
of InDels in single-base pairs or small repeat units can be
detected [21–24]. This method does not work well, however,
in detecting large InDels (>50pb) because the gradient ﬂow
is designed for small (deletion) sequences [25].
In the present study, we chose to analyze the ampli-
con using the DHPLC instrument at a nondenaturating
temperature, using the same PCR product to ﬂow through
the chromatography column under two diﬀerent gradients,
which were based on the predicted D and I allele sequences.
We compared this DHPLC method with the conventional
and conﬁrmatory methods for ACE I/D polymorphism
genotyping, and we propose this methodology for genotyp-
ing InDels throughout the genome.
2. MATERIALS AND METHODS
2.1. Samples
Genomic DNA was directly extracted from 3mL of whole
blood [26] from 335 volunteers with mixed ethnic back-
grounds, after obtaining their written informed consent.
2.2. ConventionalPCR
Genotyping of the ACE gene was performed in all 335
samples, as described by Rigat et al. [12]. The primers anneal
outside the insertion/deletion region in intron 16 of the
ACE gene and yield a PCR product of 490 base pairs (bp)
in the case of the insertion allele or 190bp in the case of
deletion allele. Depending on the presence or absence of the
insertion allele, the genotype of the subjects was classiﬁed as
II(homozygotefortheinsertionallele),DD(homozygotefor
the deletion allele), or ID (heterozygote).
2.3. ConﬁrmatoryPCR
Each sample found to be of the DD genotype using the
conventional method was subjected to a second independent
PCR ampliﬁcation with a set of primers that recognize the
Alu insertion-speciﬁc sequence, as described by Shanmugan
et al. [15]. A PCR product of 408bp indicated the insertion
allele.Renata Guedes Koyama et al. 3
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CTGGAGACCACTCCCATCCTTTCTCCCATTTCTCTAGACCTGCT GCCTATA
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Sequence of ACE D:
CTGGAGACCACTCCCATCCTTTCTCCCATTTCTCTAGACCTGCTGCCTATATAC
AGTCACTTTTATGTGGTTTCGCCAATTTTATTCCAGCTCTGAAATTCTCTGAGCT
CCCCTTACAAGCAGAGGTGAGCTAAGGGCTGGAGCTCAAGGCATTCAAACCCCT
ACCAGATCTGACGAATGTGATGGCCACATC
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Figure 1: Observed chromatograms patterns in the DHPLC system
at 50◦C after submitting the same samples to the two conditions.
(a) ACE I sequence and chromatogram. (b) ACE D sequence and
chromatogram. The lines in the upper part of both chromatograms
show I/I genotype, the line in the middle is the D/D genotype, and
the line below is the I/D genotype. The homozygotes show a peak
when their sequences are analyzed, and the heterozygotes show a
peak in both analyses.
2.4. DHPLCanalysis
DHPLCanalysiswasperformedineachsamplefoundtohave
the DD genotype using the conventional method [12].
Genomic DNA samples were subjected to PCR using
10mM of forward primer and 10mM of reverse primer,
as described by Rigat et al. [12], in a solution containing
1.0mM MgCl+2, 2.5mM Tris-HCl (pH 9.0), 1.0mM each
of dNTP, and 1U of Platinum Taq DNA polymerase
(Invitrogen, SP, Brazil).
We entered the two predicted sequences, representing
the ACE gene I and D alleles (NCBI ref X62855, SNP:
rs13447447-Figure 1), into the system to create two diﬀerent
gradients of buﬀers and acetonitrile. The system control
software (Transgenomic Navigator Software version 1.5.4,
Transgenomic Inc., USA) gave the ﬂow rate of the reagents
basedonthepredictedsequences.Thereversephasegradient
was performed under two diﬀerent conditions, one for each
allele. In condition 1, for the D sequence, the gradient was
initially set to 47.2% 0.1M TEAA, pH 7.0 (buﬀer A) mixed
with 52.8% 0.1M TEAA, pH 7.0, v/v 25% acetronitrile
(buﬀer B). At the end point (5 minutes), the gradient was
38.2% buﬀer A and 61.8% buﬀer B. The gradient used for
condition 2, for the large sequence (I), started with 39.2% of
buﬀer A mixed with 60.8% of buﬀer B, and at the end point
(5 minutes) the gradient was composed of 30.2% buﬀer A
and 69.8% buﬀer B.
Eight µL of PCR product was applied twice to a DNASep
column (Transgenomic-Wave 3500A DHPLC system, ref
DNA 99 3510, 4.6mm × 50mm, Transgenomic Inc., USA).
Elution of DNA was detected by 260nmUV absorbance,
and the chromatograms were analyzed by the presence or
absenceofampliconat50◦Cwiththetwogradientsandﬂows
(Figure 1).
3. RESULTS
From the initial 335 samples, 95 were found to be of the
DDgenotype.Thesewerereevaluatedusingtheconventional
genotyping method, as well as the conﬁrmatory and DHPLC
methods for comparison. We conﬁrmed that 81.05% of the
95 samples were the DD genotype. However, in using the
DHPLC and conﬁrmatory methods, 18.95% of the samples
proved to be the ID genotype. In two cases (2.1%) only the
DHPLC detected the ID genotype and in another two cases
(2.1%) only conﬁrmatory PCR detected the ID genotype
(Table 1).
An example of the pattern found using the DHPLC
method is shown in Figure 1. The DD genotype was only
detected by the speciﬁc DHPLC gradient and ﬂow designed
for the shorter PCR product (see Mat&Meth DHPLC
condition 1), and the II genotype was detected only by the
speciﬁc DHPLC gradient and ﬂow designed for the larger
PCR product (see Mat&Meth DHPLC condition 2). When
we had heterozygosity (I/D genotype sample), we observed
peaks in the two diﬀerent gradient and ﬂow conditions.
4. DISCUSSION
In this report, we established the use of DHPLC for rapid
screening of large InDels such as ACE I/D polymorphisms.
Compared to other genotyping techniques, DHPLC oﬀers
several technical advantages. In a large-scale genotyping
setting such as population screening, the adaptability of
DHPLC, along with its high throughput, should signiﬁcantly
reduce overall processing time. Also, the autorun mode of
DHPLC signiﬁcantly decreases handling time without the
loss of assay speciﬁcity [27–29], and screening is relatively
quick and easy (8 minutes for total run per sample after
PCR, including sample injection, column equilibration, and
cleaning).
The method presented here oﬀers several speciﬁc advan-
tages over the other methods used to genotype ACE I/D
polymorphisms, in which the false-positive mistyping of the
DD genotype is a concern. The probability of mistyping4 Journal of Biomedicine and Biotechnology
Table 1: Frequencies of DD only genotype using DHPLC and conﬁrmatory methods.
Genotype % (n) Conﬁrmatory % (n)D H P L C % ( n) DHPLC + Conﬁrmatory % (n)
Concordances Diﬀerences
DD 100 (95) 81.05 (77) 81.05 (77) 78.95 (75) 2.11 (2)
ID 0 18.95 (18) 18.95 (18) 16.84 (16) 2.11 (2)
has been cited by some authors to range from 5–10%
[13, 14], but in our samples we detected a discrepancy
in 19% of cases. Certainly, this accuracy depends on the
observer’s expertise in performing PCR gel electrophoresis
analyses. The conﬁrmatory PCR method, used to overcome
this problem, is time consuming since two PCRs must be
performed, and some believe that the results (the PCR bands
in the gel) should be assessed by more than one observer to
avoidmisinterpretation [15].Thismethodhasbeenreported
to have 100% accuracy in genotyping the ID heterozygote.
However, in our study, the ID heterozygote was not detected
in2%ofallsamples.Chiangetal.[16]alsoshoweddecreased
detection of the I/D heterozygote using this method relative
to the step-down approach. DHPLC has the advantage
of genotyping many samples without supervision and the
DHPLC can run overnight with automatically generated
results. If the PCR conditions is carefully optimized and
the injected amplicon is unique and pure, the exit pattern
shows only one clear and recognizable peak, thus avoiding
the necessity of analysis by two independent observers.
DHPLCmethodologymakesgenotypingofslightlymod-
iﬁed DNA, like SNPs and small InDels (1 to 50bp) feasible
for numerous samples and has been used in many studies
[30–32]. Traditionally, DHPLC has not been recommended
forlargeInDels,becausethegradientﬂowisdesignedforone
sequence(deletion,e.g.),thusrenderingtheother(insertion)
unrecognizable [24, 25]. We observed this phenomenon
when we analyzed the ACE amplicon in a single DHPLC
run, but in this study we demonstrated that it is possible to
overcomethisproblemwithtwoseparaterunsusingdiﬀerent
gradientﬂowsforeachallele.Therefore,DHPLCmaybeused
to detect large InDels (up to ∼2 0 0 b p )i fo n ea n a l y z e st h e
amplicon using two nondenaturating runs with two buﬀer
gradients and two ﬂow adjustments.
To the best of our knowledge, this is the ﬁrst report
of a DHPLC selective approach to genotyping large InDels
using two sequences input for two gradients of buﬀers and
two ﬂow adjustments to analyze both sequences separately.
A multiplex-PCR coupled to HPLC analysis under nonde-
naturating conditions for detection of large InDels [33]h a s
already been proposed, but small nonspeciﬁc peaks might
hamper the analysis.
We have shown in this study that this DHPLC method
is highly eﬃcient and reproducible in the detection and
genotyping of the ACE ID polymorphism, which has been
a challenging goal to achieve. In our study, two cases with the
ID genotype were not detected by DHPLC but were detected
by conﬁrmatory PCR. In another two cases, only DHPLC,
but not conﬁrmatory PCR, detected the ID genotype. There
is no clear explanation for this, but we conclude that
identiﬁcation of large InDels, like the ACE ID, are very
diﬃcult to genotype using only one methodology. Moreover,
in conﬁrmatory PCR a primer inside the Alu sequence is
used, and the two samples not detected by DHPLC could
have ampliﬁed other genes to Alu insertion polymorphisms.
Comparing DHPLC and the conﬁrmatory PCR method-
ology used for the same purpose, DHPLC has the advantages
of ease of handling and signiﬁcantly fewer problems with
data interpretation. Besides its application in ACE I/D
polymorphism, DHPLC is a powerful tool for clinical and
population analysis of InDels in general, which may greatly
increase laboratory throughput.
5. CONCLUSIONS
InDels may be observed asone- or multibase pair expansions
of repeat units, besides random DNA sequences as trans-
poson insertions and deletions and their detection is used
for the purpose of genetic mapping and diagnostics. The
DHPLC method usually can detect small repeat units under
nondenaturating conditions. With the approach described
in the present study, DHPLC can be used to genotype large
InDels, as demonstrated in the detection of ACE gene I/D
polymorphisms. This method could be useful in clinical
applications, and carries the advantage of avoiding possible
gelmisinterpretationand,thus,genotypemisinterpretations.
In conclusion, the DHPLC design described in this study is
an alternative approach for large InDel detection and could
be used in studies that evaluate this kind of polymorphism.
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